These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29297305)

  • 1. Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection.
    Pathak N; Lai ML; Chen WY; Hsieh BW; Yu GY; Yang JM
    BMC Bioinformatics; 2017 Dec; 18(Suppl 16):548. PubMed ID: 29297305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zika Virus NS3 Protease Pharmacophore Anchor Model and Drug Discovery.
    Pathak N; Kuo YP; Chang TY; Huang CT; Hung HC; Hsu JT; Yu GY; Yang JM
    Sci Rep; 2020 Jun; 10(1):8929. PubMed ID: 32488021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing.
    Pathak N; Chen YT; Hsu YC; Hsu NY; Kuo CJ; Tsai HP; Kang JJ; Huang CH; Chang SY; Chang YH; Liang PH; Yang JM
    ACS Nano; 2021 Jan; 15(1):857-872. PubMed ID: 33373194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Montelukast as flavivirus NS2B-NS3 protease inhibitor by inverse virtual screening and experimental validation.
    Jiang H; Zhang Y; Wu Y; Cheng J; Feng S; Wang J; Wang X; Cheng M
    Biochem Biophys Res Commun; 2022 May; 606():87-93. PubMed ID: 35339757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue protease activity: the structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target.
    Phong WY; Moreland NJ; Lim SP; Wen D; Paradkar PN; Vasudevan SG
    Biosci Rep; 2011 Oct; 31(5):399-409. PubMed ID: 21329491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
    Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
    J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold.
    Aleshin AE; Shiryaev SA; Strongin AY; Liddington RC
    Protein Sci; 2007 May; 16(5):795-806. PubMed ID: 17400917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses.
    Del Rosario García-Lozano M; Dragoni F; Gallego P; Mazzotta S; López-Gómez A; Boccuto A; Martínez-Cortés C; Rodríguez-Martínez A; Pérez-Sánchez H; Manuel Vega-Pérez J; Antonio Del Campo J; Vicenti I; Vega-Holm M; Iglesias-Guerra F
    Bioorg Chem; 2023 Apr; 133():106408. PubMed ID: 36801791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Transactions of NS3 and NS5 in Flaviviral RNA Replication.
    Tay MYF; Vasudevan SG
    Adv Exp Med Biol; 2018; 1062():147-163. PubMed ID: 29845531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.
    Chatel-Chaix L; Fischl W; Scaturro P; Cortese M; Kallis S; Bartenschlager M; Fischer B; Bartenschlager R
    J Virol; 2015 Jul; 89(14):7170-86. PubMed ID: 25926641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
    Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
    Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering key residues of dengue virus NS2b-NS3-protease: New binding sites for antiviral inhibitors design.
    Aguilera-Pesantes D; Robayo LE; Méndez PE; Mollocana D; Marrero-Ponce Y; Torres FJ; Méndez MA
    Biochem Biophys Res Commun; 2017 Oct; 492(4):631-642. PubMed ID: 28343993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Backbone modifications in peptidic inhibitors of flaviviral proteases.
    Jakob AKMH; Sundermann TR; Klein CD
    Bioorg Med Chem Lett; 2019 Aug; 29(15):1913-1917. PubMed ID: 31176698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase.
    Sweeney NL; Hanson AM; Mukherjee S; Ndjomou J; Geiss BJ; Steel JJ; Frankowski KJ; Li K; Schoenen FJ; Frick DN
    ACS Infect Dis; 2015 Mar; 1(3):140-148. PubMed ID: 26029739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
    Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
    Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD; Tripathi IP; Mishra SK
    J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore-Model-Based Drug Repurposing for the Identification of the Potential Inhibitors Targeting the Allosteric Site in Dengue Virus NS5 RNA-Dependent RNA Polymerase.
    Kumar S; Bajrai LH; Faizo AA; Khateb AM; Alkhaldy AA; Rana R; Azhar EI; Dwivedi VD
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond Basicity: Discovery of Nonbasic DENV-2 Protease Inhibitors with Potent Activity in Cell Culture.
    Kühl N; Leuthold MM; Behnam MAM; Klein CD
    J Med Chem; 2021 Apr; 64(8):4567-4587. PubMed ID: 33851839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture.
    Steuer C; Gege C; Fischl W; Heinonen KH; Bartenschlager R; Klein CD
    Bioorg Med Chem; 2011 Jul; 19(13):4067-74. PubMed ID: 21641807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.